Insilico Medicine
| Type | Public |
|---|---|
| SEHK: 3696 | |
| Industry | Biotechnology |
| Founded | 2014 |
| Founder | Alex Zhavoronkov |
| Headquarters | 1000 Massachusetts Avenue, |
Number of locations | 6 |
Area served | Artificial intelligence, deep learning |
| Key people | Alex Zhavoronkov, PhD, Feng Ren, PhD, Alex Aliper |
| Services | Drug discovery |
| Website | insilico |
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company applies genomics, big data analysis, and deep learning for in silico drug discovery.